Close
Smartlab Europe
Achema middle east

News

Massachusetts Hospital to Assess Mallinckrodt’s Nitric Oxide Treatment for COVID-19

Mallinckrodt and Massachusetts General Hospital teamed up to evaluate the potential benefits of inhaled nitric oxide as a treatment for pulmonary complications in patients infected with COVID-19. The partnership will assess the benefit of INOmax (nitric oxide) gas in mechanically...

Trio pharmaceuticals and ajinomoto bio pharma services enter into a development collaboration for a novel antibody therapeutic

Trio Pharmaceuticals, Inc., a cancer therapeutics company developing novel dual action antibody drugs, and Ajinomoto Bio-Pharma Services, have entered a development collaboration to evaluate AJICAP, a site-specific conjugation technology offered by Aji Bio-Pharma for the development of TRIObody Drug...

Gilead’s drug remdesivir gets US FDA’s emergency use authorisation for COVID-19

Gilead was granted EUA by U.S. FDA for the investigational antiviral remdesivir to treat COVID-19. The EUA will facilitate broader use of remdesivir to treat hospitalized patients with severe COVID-19 disease, enabling access to remdesivir at additional hospitals across...

Inspirata Hosts Fireside Chat on the Future of Pathology in a Post-COVID-19 World

Cancer informatics and digital pathology solution provider Inspirata is setting its sights on the post-COVID-19 future. Following the drastic social distancing measures implemented across the world, Inspirata announced its COVID-19 Free Remote Pathology Initiative in March, which allows healthcare institutions...

MedPharm Develops Model to Support Coronavirus Pharmaceutical Development

MedPharm, a leading clinical development organization in topical and transdermal drug delivery, has expanded its innovative testing models to support pharmaceutical development programs targeting Coronavirus treatments. These models allow companies to assess therapeutic effectiveness in nasal, airway (bronchial), and...

ARTES Biotech to Develop VLP SARS-CoV-2 Vax Candidates

ARTES Biotechnology, a biotech company specializing in process development for recombinant vaccines, entered development of SARS-CoV-2 vaccine candidates based on its virus-like particle (VLP) based platform technologies METAVAX and SplitCore. METAVAX is a platform for the development of vaccines built...

Sino-Pack2020 and PACKINNO2020 will be further postponed from June 2020 to March 2021

Postponement of the 27th China International Exhibition on Packaging Machinery & Materials (Sino-Pack2020) cum China (Guangzhou) International Exhibition on Packaging Products (PACKINNO2020) Since the occurrence of COVID-19, we have been closely monitoring the situation. On 8th April 2020, the State...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »